Open: 45.9 Close: 45.65 Change: -0.25

Today's Summary

analysts expect royalty Pharma to report an earnings per share (EPS) of $1.33. investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.royalty Pharma will retain 70% of royalties on Ziihera sales. the note will be secured by 30% of future royalties from the global sales of ziiheran. royalties will be repaid by the company by December 31, 2033.royalties from these transactions are creating a new market opportunity for royalty-based funding. he joins royalty Pharma from Morgan Stanley, where he was head of Asia Pacific Healthcare Investment Banking.